학술논문
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
Document Type
Article
Author
Source
In ESMO Open May 2024 9(5)
Subject
Language
ISSN
2059-7029